Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO
Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
Imcyse announces changes in management and board, appoints Thomas Taapken as executive chairman
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate
Lynred IR detector onboard Chandrayaan-2 expedition to Moon’s South Pole
Traxens closes €20M Series C financing round with key strategic partners
Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections
CarThera receives FDA approval for Phase 1/2a trial in glioblastoma
